Skip to main content

Molecular characterization of bovine CD26 upregulated by a staphylococcal superantigen

Abstract.

In this report, we describe the cloning, sequencing, and expression of the bovine orthologue of CD26 (BoCD26). Several monoclonal antibodies specific for a molecule, activation molecule 3 (ACT3), aberrantly expressed on superantigen-stimulated bovine CD8+ lymphocytes, reacted with recombinant BoCD26 expressed in COS-7 and CHO cells. We also showed that human CD8+ T cells stimulated by a superantigen expressed CD26 at high levels. These results demonstrate that ACT3 is identical to BoCD26 and suggest that CD26 upregulation on CD8+ T cells is a general phenomenon of superantigens and not limited to their effects on bovine cells.

This is a preview of subscription content, access via your institution.

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lee, SU., Park, YH., Davis, W.C. et al. Molecular characterization of bovine CD26 upregulated by a staphylococcal superantigen. Immunogenetics 54, 216–220 (2002). https://doi.org/10.1007/s00251-002-0456-6

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00251-002-0456-6

  • Bovine CD26 DPP4 Human Superantigen